Status:

COMPLETED

Galectin-3 as a Biomarker in Patients With Chagas Disease

Lead Sponsor:

Hospital Sao Rafael

Conditions:

Chagas Disease

Eligibility:

All Genders

18-70 years

Brief Summary

The purpose of this study is to analyze the efficacy of Galectin-3 as a biomarker on the Chagas Disease prognosis. This analysis will be done through the correlation between the plasmatic levels of th...

Detailed Description

Previous studies indicate that activated macrophages secrete Galectin-3, a molecule that is involved in the development of fibrosis and tissue rearrangement in the liver, kidney and the heart. Its pla...

Eligibility Criteria

Inclusion

  • Chagas Disease diagnosis confirmed by 2 different serologies
  • Diagnosis of indeterminate form or cardiac form, with and without ventricular dysfunction.

Exclusion

  • Significant valve disease defined as aortic stenosis with a gradient of VE/Ao \> 50 mmHg
  • Mitral stenosis with a valve area inferior than 1,5 cm2
  • Severe or moderate aortic and/or mitral regurgitation
  • Chronic use of immunosuppressive agents
  • Dialysis treatment of terminal renal failure
  • Fever on the last 48 hours or evidence of systemic infection in activity according to the definition of sepsis of the ACCP/SCCM (American College os Chest Physicians/Society of Critical Care Medicine)
  • Current abusive use of alcohol or illicit drugs (Based on the DSM IV)
  • Any other comorbidities that impact patient's survival within the next 2 years
  • Liver disease in activity
  • Continuous use of steroids as treatment for COPD
  • Hematologic, neoplastic or bone diseases
  • Homeostasis disturbances
  • Inflammatory diseases or chronic infectious diseases

Key Trial Info

Start Date :

January 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2015

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01842854

Start Date

January 1 2011

End Date

June 1 2015

Last Update

November 28 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital São Rafael

Salvador, Estado de Bahia, Brazil, 41253-190

Galectin-3 as a Biomarker in Patients With Chagas Disease | DecenTrialz